Oral HYCAMTIN Plus Whole Brain Radiation Therapy In Treatment Of Brain Metastases Resulting From Non-Small Lung Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

472

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

July 31, 2012

Study Completion Date

September 30, 2013

Conditions
Lung Cancer, Non-Small Cell
Interventions
DRUG

HYCAMTIN, oral capsules

topotecan oral capsules 1.1 mg/m2

RADIATION

Radiation

Whole brain radiation

Trial Locations (88)

1529

GSK Investigational Site, Budapest

2045

GSK Investigational Site, Törökbálint

3233

GSK Investigational Site, Mátraháza

3529

GSK Investigational Site, Miskolc

4400

GSK Investigational Site, Nyíregyháza

5703

GSK Investigational Site, Gyula

7623

GSK Investigational Site, Pécs

8000

GSK Investigational Site, Székesfehérvár

8900

GSK Investigational Site, Zalaegerszeg-Pozva

9024

GSK Investigational Site, Győr

9300

GSK Investigational Site, Csorna

9700

GSK Investigational Site, Szombathely

10467

GSK Investigational Site, The Bronx

12206

GSK Investigational Site, Albany

14215

GSK Investigational Site, Buffalo

29403

GSK Investigational Site, Charleston

33606

GSK Investigational Site, Tampa

33612

GSK Investigational Site, Tampa

33805

GSK Investigational Site, Lakeland

35294

GSK Investigational Site, Birmingham

39216

GSK Investigational Site, Jackson

42003

GSK Investigational Site, Paducah

43235

GSK Investigational Site, Columbus

46227

GSK Investigational Site, Indianapolis

53792

GSK Investigational Site, Madison

55455

GSK Investigational Site, Minneapolis

60007

GSK Investigational Site, Elk Grove Village

60068

GSK Investigational Site, Park Ridge

60077

GSK Investigational Site, Skokie

60612

GSK Investigational Site, Chicago

61108

GSK Investigational Site, Rockford

61401

GSK Investigational Site, Galesburg

64154

GSK Investigational Site, Kansas City

65201

GSK Investigational Site, Columbia

66205

GSK Investigational Site, Westwood

68510

GSK Investigational Site, Lincoln

70006

GSK Investigational Site, Metairie

71913

GSK Investigational Site, Hot Springs

75090

GSK Investigational Site, Sherman

75137

GSK Investigational Site, Duncanville

76022

GSK Investigational Site, Bedford

76104

GSK Investigational Site, Fort Worth

77479

GSK Investigational Site, Sugarland

78412

GSK Investigational Site, Corpus Christi

79415

GSK Investigational Site, Lubbock

80012

GSK Investigational Site, Aurora

85304

GSK Investigational Site, Glendale

87109

GSK Investigational Site, Albuquerque

89106

GSK Investigational Site, Las Vegas

89135

GSK Investigational Site, Las Vegas

92801

GSK Investigational Site, Anaheim

94523

GSK Investigational Site, Pleasant Hill

98201

GSK Investigational Site, Everett

98684

GSK Investigational Site, Vancouver

105229

GSK Investigational Site, Moscow

128128

GSK Investigational Site, Moscow

197022

GSK Investigational Site, Saint Petersburg

197758

GSK Investigational Site, Saint Petersburg

249036

GSK Investigational Site, Obninsk

394062

GSK Investigational Site, Voronezh

420111

GSK Investigational Site, Kazan'

460021

GSK Investigational Site, Orenburg

91010-3000

GSK Investigational Site, Duarte

14215-1199

GSK Investigational Site, Buffalo

97401-8122

GSK Investigational Site, Eugene

75320-2510

GSK Investigational Site, Dallas

E1C 8X3

GSK Investigational Site, Moncton

L8V 5C2

GSK Investigational Site, Hamilton

K7L 5P9

GSK Investigational Site, Kingston

N6A 4L6

GSK Investigational Site, London

M5G 2M9

GSK Investigational Site, Toronto

J4V 2H1

GSK Investigational Site, Greenfield Park

H1T 2M4

GSK Investigational Site, Montreal

H2L 4M1

GSK Investigational Site, Montreal

G1R 2J6

GSK Investigational Site, Québec

J1H 5N4

GSK Investigational Site, Sherbrooke

15-540

GSK Investigational Site, Bialystok

85-769

GSK Investigational Site, Bydgoszcz

80-211

GSK Investigational Site, Gdansk

31-115

GSK Investigational Site, Krakow

10-226

GSK Investigational Site, Olsztyn

10-357

GSK Investigational Site, Olsztyn

60-569

GSK Investigational Site, Poznan

115 478

GSK Investigational Site, Moscow

129 128

GSK Investigational Site, Moscow

975 17

GSK Investigational Site, Banská Bystrica

826 06

GSK Investigational Site, Bratislava

949 01

GSK Investigational Site, Nitra

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT00390806 - Oral HYCAMTIN Plus Whole Brain Radiation Therapy In Treatment Of Brain Metastases Resulting From Non-Small Lung Cancer | Biotech Hunter | Biotech Hunter